Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line Stavudine-containing antiretroviral therapy: Programmatic implications for countries phasing out Stavudine
- Publication date
- 1 January 2013
- Publisher
- UNIV CHICAGO PRESS, 1427 E 60TH ST, CHICAGO, USA, IL, 60637-2954